FNY Managed Accounts’s Insmed INSM Stock Holding History

FNY Managed Accounts’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-107	Closed	-$3K	–	706
2017 Q4	$3K	Buy	+107	New	+$3.16K	﹤0.01%	411

Other funds holding INSM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

FNY Managed Accounts's INSM Position: Q1 2018 in Review

FNY Managed Accounts sold out of Insmed (INSM) in Q1 2018, closing a stake of 107 shares — an estimated $3K sold.

FNY Managed Accounts first reported a position in INSM in Q4 2017 and held it in 1 quarter. The position peaked at $3K in Q4 2017. 127 funds tracked by Wall St. Rank hold INSM as of Q1 2018.

FNY Managed Accounts reported no remaining Insmed position as of Q1 2018 after selling out during the quarter.
FNY Managed Accounts sold 107 Insmed shares in Q1 2018, an estimated $3K.
FNY Managed Accounts first reported a position in Insmed in Q4 2017 and held it in 1 quarter.
FNY Managed Accounts's Insmed position peaked at $3K in Q4 2017.
127 funds tracked by Wall St. Rank held Insmed as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.